Farida Nato
6Patents
1h-index
13Co-inventors
44Inventor score
Filing activity: Jul 2, 2004 → Jun 20, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8124380B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 6 | Active |
| US9446109B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 0 | Active |
| US10376593B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | Emerging Cross-Sectional Technologies | 0 | Active |
| US8815239B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | Chemistry; Metallurgy | 0 | Active |
| US10087242B2 | Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X | Chemistry; Metallurgy | 0 | Active |
| US8350019B2 | Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their use | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.